Pharmacovigilance in clinical trials

Pharmacovigilance in clinical trials

Saved in:

Bibliographic Details
Main Authors:	Ilić Katarina, Ugrešić Nenad
Format:	Article
Language:	English
Published:	Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2007-01-01
Series:	Vojnosanitetski Pregled
Subjects:	adverse drug reaction reporting systems drug evaluation clinical trials drug utilization review
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2007/0042-84500704265I.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacovigilance as an imperative of modern medicine - experience from Montenegro
by: Mugoša Snežana, et al.
Published: (2017-01-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

Integrating pharmacovigilance into the routine of pharmacy department: experience of nine years
by: Ariadna Pérez-Ricart, et al.
Published: (2019-07-01)

Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia
by: E. N. Tkhoseva, et al.
Published: (2022-06-01)

Role of Pharmacovigilance in Drug Safety Monitoring
by: Anju E. Paul, et al.
Published: (2025-07-01)

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)

A realworld pharmacovigilance study of trazodone based on the FDA adverse event reporting system
by: Yong Yu, et al.
Published: (2025-02-01)

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019-09-01)

Network analysis of adverse event patterns following immunization with mRNA COVID-19 vaccines: real-world data from the European pharmacovigilance database EudraVigilance
by: Renato Ferreira-da-Silva, et al.
Published: (2025-02-01)

Clinical pharmacology in health care service
by: Janković Slobodan M.
Published: (2005-01-01)

KNOWLEDGE, ATTITUDE AND PRACTICE AMONG HEALTHCARE PROFESSIONALS TOWARDS ADR REPORTING IN ABBOTTABAD PAKISTAN
Published: (2021-12-01)

Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries
by: Mohammed Gebre Dedefo, et al.
Published: (2025-08-01)

Analysis of pharmacy organisation staff awareness of pharmacovigilance
by: R. I. Yagudina, et al.
Published: (2025-06-01)

Assessment of pharmacovigilance knowledge and ADR reporting skills in undergraduate medical students using the OSPA model
by: T.Y. Sree Sudha, et al.
Published: (2025-12-01)

Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases
by: Chunsu Liang, et al.
Published: (2024-12-01)

Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
by: Jiazhen Jiang, et al.
Published: (2025-05-01)

Off-Label Drug Use in Pediatric Practice: Unsolved Problems
by: A. R. Titova, et al.
Published: (2015-10-01)

Clinical pharmacology in Serbia: The time for new challenges
by: Dragojević-Simić Viktorija, et al.
Published: (2007-01-01)

Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
by: Jiazhen Jiang, et al.
Published: (2025-06-01)

Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program
by: Tinashe Mudzviti, et al.
Published: (2012-11-01)

Clinical and pharmacological monitoring of drug safety in pediatrics
by: N. V. Verlan, et al.
Published: (2016-05-01)

Rational Organisation of Adverse Drug Reaction Monitoring
by: L. V. Shukil, et al.
Published: (2022-10-01)

Knowledge, attitude, and practice among community pharmacists toward adverse drug reaction reporting and pharmacovigilance: A nationwide survey
by: Tahani Alwidyan, et al.
Published: (2025-06-01)

Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system
by: Qi Song, et al.
Published: (2025-06-01)

Potential inappropriate medications and drug–drug interactions in adverse drug reactions in the elderly: a retrospective study in a pharmacovigilance database
by: Huaqiao Jiang, et al.
Published: (2025-04-01)

MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE
by: N. V. Verlan, et al.
Published: (2017-02-01)

Effectiveness of mobile applications in enhancing adverse drug reaction reporting: a systematic review
by: Liyanage PH, et al.
Published: (2025-05-01)

Analysis of Data on Adverse Drug Reactions and Functional Flaws of the Pharmacovigilance System Associated with Self-Treatment with Antibiotics
by: N. V. Verlan, et al.
Published: (2022-10-01)

Safety of Lipid-Lowering Therapy with Statins according to a Regional Pharmacovigilance Centre
by: E. O. Kochkina, et al.
Published: (2023-09-01)

Optimization of antidepressant treatment by pharmacogenomics: a case report
by: Ying Zhang, et al.
Published: (2025-01-01)

Safety profile of belatacept in a real-life setting: disproportionality analysis of the WHO pharmacovigilance database
by: Alexandre O. Gérard, et al.
Published: (2025-08-01)

Monitoring of drug safety
by: B. K. Romanov, et al.
Published: (2022-06-01)

A pharmacovigilance study on probiotic preparations based on the FDA Adverse Event Reporting System from 2005 to 2023
by: Yitong Wang, et al.
Published: (2025-05-01)

Methodology for Creating a Risk Management System for Drug-Drug Interactions
by: A. A. Taube, et al.
Published: (2024-03-01)

Advances in Pharmacovigilance in India: Role of Mobile Application
by: Rajpushpa Labh, et al.
Published: (2020-07-01)

Spontaneous Adverse Drug Reaction Reporting of Congenital Malformations: A Danish National Register Study
by: Ulrik Lausten-Thomsen, et al.
Published: (2025-06-01)

Real world pharmacovigilance comparison of viloxazine and dextroamphetamine adverse reaction profiles
by: Lijun Wang, et al.
Published: (2025-08-01)

Adverse events associated with herbal medicine products reported in the Korea Adverse Event Reporting System from 2012 to 2021
by: Yujin Choi, et al.
Published: (2024-10-01)

Exposure to potential drug-antimicrobial agent interactions in primary health care
by: Nikolić Božana, et al.
Published: (2018-01-01)

Evaluation of Oral Antidiabetes Drugs in Patients of Uncontrolled Type 2 Diabetes Mellitus: A Cohort Study
by: Samiksha J Sonar, et al.
Published: (2025-04-01)